Hypoxia-dependent mRNA expression pattern of splicing factor YT521 and its impact on oncological important target gene expression
- PMID: 23765422
- DOI: 10.1002/mc.22045
Hypoxia-dependent mRNA expression pattern of splicing factor YT521 and its impact on oncological important target gene expression
Abstract
The ubiquitously expressed splicing factor YT521 (YTHDC1) is characterized by alternatively spliced isoforms with regulatory impact on cancer-associated gene expression. Our recent findings account for the prognostic significance of YT521 in endometrial cancer. In this study, we investigated the hypoxia-dependency of YT521 expression as well as its differential isoform activities on oncological important target genes. YT521's potential regulatory influence on splicing was investigated by a minigene assay for the specific target gene CD44. Functional splicing analysis was performed by YT521 knock-down or overexpression, respectively. In addition, YT521 expression was determined under hypoxia. The two protein-generating YT521 mRNA isoforms 1 and 2 caused a comparable, specific induction of CD44v alternative splicing (P < 0.01). In a number of oncological target genes, YT521 upregulation significantly altered BRCA2 expression pattern, while YT521 knock-down created a significant regulatory impact on PGR expression, respectively. Hypoxia induced a specific switch towards the processing of two non-protein-coding mRNA variants, of which one is described for the first time in this study. The presented study underlines the comparable regulatory potential of both YT521 isoforms 1 and 2, on the investigated target genes in vivo and in vitro. Hypoxia induces a specific switch in YT521 expression pattern towards the two non-protein coding mRNA variants, the already characterized isoform 3 and the newly discovered exon 8-skipping isoform. The altered YT521 alternative splicing is functionally coupled with nonsense-mediated decay and can be interpreted as regulated unproductive splicing and transcription with consecutive impact on the processing of specific cancer-associated genes, such as BRCA2 and PGR.
Keywords: BRCA2; YT521; cancer; hypoxia; splicing.
© 2013 Wiley Periodicals, Inc.
Similar articles
-
Alternative splicing-related factor YT521: an independent prognostic factor in endometrial cancer.Int J Gynecol Cancer. 2010 May;20(4):492-9. doi: 10.1111/IGC.0b013e3181d66ffe. Int J Gynecol Cancer. 2010. PMID: 20686370
-
CD44 alternative splicing and hnRNP A1 expression are associated with the metastasis of breast cancer.Oncol Rep. 2015 Sep;34(3):1231-8. doi: 10.3892/or.2015.4110. Epub 2015 Jul 6. Oncol Rep. 2015. PMID: 26151392
-
Splicing factor Tra2-beta1 is specifically induced in breast cancer and regulates alternative splicing of the CD44 gene.Cancer Res. 2006 May 1;66(9):4774-80. doi: 10.1158/0008-5472.CAN-04-3294. Cancer Res. 2006. PMID: 16651431
-
RNA splicing and splicing regulator changes in prostate cancer pathology.Hum Genet. 2017 Sep;136(9):1143-1154. doi: 10.1007/s00439-017-1792-9. Epub 2017 Apr 5. Hum Genet. 2017. PMID: 28382513 Free PMC article. Review.
-
Regulation of alternative splicing of CD44 in cancer.Cell Signal. 2014 Oct;26(10):2234-9. doi: 10.1016/j.cellsig.2014.07.011. Epub 2014 Jul 13. Cell Signal. 2014. PMID: 25025570 Review.
Cited by
-
Linking the YTH domain to cancer: the importance of YTH family proteins in epigenetics.Cell Death Dis. 2021 Apr 1;12(4):346. doi: 10.1038/s41419-021-03625-8. Cell Death Dis. 2021. PMID: 33795663 Free PMC article. Review.
-
The Oncogene Metadherin Interacts with the Known Splicing Proteins YTHDC1, Sam68 and T-STAR and Plays a Novel Role in Alternative mRNA Splicing.Cancers (Basel). 2019 Aug 23;11(9):1233. doi: 10.3390/cancers11091233. Cancers (Basel). 2019. PMID: 31450747 Free PMC article.
-
The RNA Modification N6-methyladenosine and Its Implications in Human Disease.Genomics Proteomics Bioinformatics. 2017 Jun;15(3):154-163. doi: 10.1016/j.gpb.2017.03.002. Epub 2017 May 19. Genomics Proteomics Bioinformatics. 2017. PMID: 28533023 Free PMC article. Review.
-
Four m6A RNA Methylation Gene Signatures and Their Prognostic Values in Lung Adenocarcinoma.Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221085373. doi: 10.1177/15330338221085373. Technol Cancer Res Treat. 2022. PMID: 35343834 Free PMC article.
-
Pan-Cancer Analysis Reveals the Prognostic Potential of the THAP9/THAP9-AS1 Sense-Antisense Gene Pair in Human Cancers.Noncoding RNA. 2022 Jul 8;8(4):51. doi: 10.3390/ncrna8040051. Noncoding RNA. 2022. PMID: 35893234 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous